Drug Trial Radar · NCT02704403
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Last checked: Nov 19, 2026Latest source record: Mar 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
2,157
Actual
Start
Mar 2016
Primary completion
Oct 28, 2020
Study completion Oct 28, 2020
Sponsor
- Lead sponsor
- GenfitIndustry
- Sponsor type
- Industry
- First posted
- Mar 10, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objectives of this study are to evaluate the effect of Elafibranor treatment compared to placebo on 1) histological improvement and 2) all-cause mortality and liver-related outcomes in patients with nonalcoholic steatohepatitis (NASH) and fibrosis.
Conditions
- Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Interventions
ElafibranorDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Elafibranor-treated Participants Relative to Placebo Achieving Resolution of Nonalcoholic Steatohepatitis Without Worsening of FibrosisTime frame: Measurement at 72 weeks
- Time to Long-term Outcome Composed of All-cause Mortality, Cirrhosis, and Liver-related Clinical OutcomesTime frame: From first randomization up to early termination of the study corresponding to 54 months (54 months being the longest duration for any given participant)
Locations
326 sites in 25 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Digestive Health Specialists of the Southeast
Dothan, Alabama
The Institute for Liver Health
Chandler, Arizona
The Institute for Liver Health
Glendale, Arizona
Banner University Medical Center Phoenix
Phoenix, Arizona
Dignity Health St. Joseph's Hospital
Phoenix, Arizona
Mayo Clinic Hospital
Phoenix, Arizona
Institute for Liver Health
Tucson, Arizona
Adobe Clinical Research, LLC
Tucson, Arizona
The University of Arizona College of Medicine Liver Research Institute
Tucson, Arizona
Liver Wellness Center
Little Rock, Arkansas
GW Research, Inc.
Chula Vista, California
Southern California Research Center
Coronado, California
University of California, San Francisco, Fresno Community Regional Medical Center
Fresno, California
Fresno Clinical Research Center
Fresno, California
University of California, San Francisco, Fresno Community Regional Medical Center
Fresno, California
Scripps Clinic Torrey Pines
La Jolla, California
University of California - San Diego
La Jolla, California
Loma Linda University Medical Center - Transplantation Insitute
Loma Linda, California
VA Long Beach Healthcare System
Long Beach, California
Keck Hospital of USC
Los Angeles, California
Ruane Clinical Research Group Inc.
Los Angeles, California
Cedars Sinai Medical Center
Los Angeles, California
Gastrointestinal Biosciences Clinical Trials LLC
Los Angeles, California
Veterans Affaires Greater Los Angeles Healthcare System, West LA VA Medical Center
Los Angeles, California
Veterans Affairs Greater Los Angeles Healthcare System
Los Angeles, California
Alliance Clinical Research
Oceanside, California
National Research Institute
Panorama City, California
Alliance Clinical Research
Poway, California
University of California, Davis Medical Center
Sacramento, California
University of California, San Diego Airway Research and Clinical Trials Center
San Diego, California
Medical Associates Research Group, Inc.
San Diego, California
VA San Diego HealthCare System
San Diego, California
Quest Clinical Research
San Francisco, California
Sutter West Bay Hospitals dba California Pacific Medical Center
San Francisco, California
University of California, San Francisco, Medical Center at Parnassus
San Francisco, California
Ventura Clinical Trials
Ventura, California
South Denver Gastroenterology
Englewood, Colorado
Yale University School of Medicine, Section of Digestive Diseases
New Haven, Connecticut
Georgetown University Hospitals
Washington D.C., District of Columbia
Showing 40 of 326 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.